Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E, Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I, Gebhard S, Pilch H, Gehrmann M, Lehr HA, Koelbl H, Hengstler JG, Schuler M.

Clin Cancer Res. 2008 Sep 15;14(18):5849-55. doi: 10.1158/1078-0432.CCR-08-0669.

2.

The humoral immune system has a key prognostic impact in node-negative breast cancer.

Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kölbl H, Gehrmann M.

Cancer Res. 2008 Jul 1;68(13):5405-13. doi: 10.1158/0008-5472.CAN-07-5206.

3.
4.

Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).

Kaufmann AM, Nieland JD, Jochmus I, Baur S, Friese K, Gabelsberger J, Gieseking F, Gissmann L, Glasschröder B, Grubert T, Hillemanns P, Höpfl R, Ikenberg H, Schwarz J, Karrasch M, Knoll A, Küppers V, Lechmann M, Lelle RJ, Meissner H, Müller RT, Pawlita M, Petry KU, Pilch H, Walek E, Schneider A.

Int J Cancer. 2007 Dec 15;121(12):2794-800.

5.

Role of the progesterone receptor for paclitaxel resistance in primary breast cancer.

Schmidt M, Bremer E, Hasenclever D, Victor A, Gehrmann M, Steiner E, Schiffer IB, Gebhardt S, Lehr HA, Mahlke M, Hermes M, Mustea A, Tanner B, Koelbl H, Pilch H, Hengstler JG.

Br J Cancer. 2007 Jan 29;96(2):241-7. Epub 2007 Jan 9.

6.

Different T-cell receptor (TCR) zeta chain expression in cervical cancer and its precursor lesions.

Zehbe I, Schmidt M, Maeurer M, Leo C, Höckel M, Pilch H.

Zentralbl Gynakol. 2006 Oct;128(5):266-70.

PMID:
17001562
7.

Juxtatumoral desmoplastic stromal reaction is associated with high tumor cell dissociation in squamous cell carcinomas of the uterine cervix.

Horn LC, Richter CE, Hentschel B, Schütz A, Pilch H, Leo C, Höckel M.

Ann Diagn Pathol. 2006 Oct;10(5):253-6.

PMID:
16979515
8.

Granular cell tumor of the breast mimicking breast cancer.

Leo C, Briest S, Pilch H, Schütz A, Horn LC, Leinung S.

Eur J Obstet Gynecol Reprod Biol. 2006 Aug;127(2):268-70. Epub 2006 Jul 18. No abstract available.

PMID:
16849031
9.

Detection of dideoxyosone intermediates of glycation using a monoclonal antibody: characterization of major epitope structures.

Puttaiah S, Zhang Y, Pilch HA, Pfahler C, Oya-Ito T, Sayre LM, Nagaraj RH.

Arch Biochem Biophys. 2006 Feb 15;446(2):186-96. Epub 2005 Dec 27.

PMID:
16406213
10.

Differential MHC class II component expression in HPV-positive cervical cancer cells: implication for immune surveillance.

Zehbe I, Höhn H, Pilch H, Neukirch C, Freitag K, Maeurer MJ.

Int J Cancer. 2005 Dec 10;117(5):807-15.

11.

Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia.

Leo C, Richter C, Horn LC, Schütz A, Pilch H, Höckel M.

Gynecol Oncol. 2005 May;97(2):602-6.

PMID:
15863166
12.

Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing.

Schmidt M, Lewark B, Kohlschmidt N, Glawatz C, Steiner E, Tanner B, Pilch H, Weikel W, Kölbl H, Lehr HA.

Breast Cancer Res. 2005;7(2):R256-66. Epub 2005 Jan 26.

13.

Naturally processed and HLA-B8-presented HPV16 E7 epitope recognized by T cells from patients with cervical cancer.

Oerke S, Höhn H, Zehbe I, Pilch H, Schicketanz KH, Hitzler WE, Neukirch C, Freitag K, Maeurer MJ.

Int J Cancer. 2005 May 1;114(5):766-78.

14.
15.

The impact of treatment for genital cancer on quality of life and body image--results of a prospective longitudinal 10-year study.

Hawighorst-Knapstein S, Fusshoeller C, Franz C, Trautmann K, Schmidt M, Pilch H, Schoenefuss G, Knapstein PG, Koelbl H, Kelleher DK, Vaupel P.

Gynecol Oncol. 2004 Aug;94(2):398-403.

PMID:
15297179
16.

[Medical informatics in obstetrics and gynecology - the actual challenge?].

Seufert R, Munz M, Pilch H, Hawighorst-Knapstein S, Pollow K.

Zentralbl Gynakol. 2003 Nov;125(11):441-5. German.

PMID:
14634872
17.

p53 expression and resistance against paclitaxel in patients with metastatic breast cancer.

Schmidt M, Bachhuber A, Victor A, Steiner E, Mahlke M, Lehr HA, Pilch H, Weikel W, Knapstein PG.

J Cancer Res Clin Oncol. 2003 May;129(5):295-302. Epub 2003 Apr 25.

PMID:
12715164
18.

[Valence of immunohistochemical analysis of endometrial carcinoma biopsy specimen].

Steiner E, Weikel W, Bahlmann F, Pilch H, Hofmann M, Schmidt M, Knapstein PG.

Zentralbl Gynakol. 2002 Oct;124(10):469-72. German.

PMID:
12712388
19.

Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.

Nilges K, Höhn H, Pilch H, Neukirch C, Freitag K, Talbot PJ, Maeurer MJ.

J Virol. 2003 May;77(9):5464-74.

20.

Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.

Steiner E, Eicher O, Sagemüller J, Schmidt M, Pilch H, Tanner B, Hengstler JG, Hofmann M, Knapstein PG.

Int J Gynecol Cancer. 2003 Mar-Apr;13(2):197-203.

PMID:
12657124
21.

CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7.

Pilch H, Hoehn H, Schmidt M, Steiner E, Tanner B, Seufert R, Maeurer M.

Zentralbl Gynakol. 2002 Aug-Sep;124(8-9):406-12.

PMID:
12655469
22.

Definition of the HLA-A2 restricted peptides recognized by human CD8+ effector T cells by flow-assisted sorting of the CD8+ CD45RA+ CD28- T cell subpopulation.

Höhn H, Jülch M, Pilch H, Kortsik C, Tully G, Neukirch C, Freitag K, Maeurer M.

Clin Exp Immunol. 2003 Jan;131(1):102-10.

23.

[Expression of c-erbB-2 and topoisomerase II alpha in relation to chemoresistance in ovarian cancer].

Tanner B, Pilch H, Schäffer U, Franzen A, Seufert R, Hengstler JG.

Zentralbl Gynakol. 2002 Mar;124(3):176-83. German.

PMID:
12070798
24.

Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor.

Pilch H, Höhn H, Neukirch C, Freitag K, Knapstein PG, Tanner B, Maeurer MJ.

Clin Diagn Lab Immunol. 2002 Mar;9(2):267-78.

25.

Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis.

Pilch H, Höhn H, Freitag K, Neukirch C, Necker A, Haddad P, Tanner B, Knapstein PG, Maeurer MJ.

Clin Diagn Lab Immunol. 2002 Mar;9(2):257-66.

26.

[Endometrial carcinoma in patients with diabetes mellitus].

Steiner E, Eicher O, Hofmann M, Weikel W, Schmidt M, Pilch H, Knapstein PG.

Zentralbl Gynakol. 2001 Nov;123(11):622-5. German.

PMID:
11797159
27.

Carcinoma of the neovagina: case report and review of the literature.

Steiner E, Woernle F, Kuhn W, Beckmann K, Schmidt M, Pilch H, Knapstein PG.

Gynecol Oncol. 2002 Jan;84(1):171-5. Review.

PMID:
11748997
28.

Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.

Ritz U, Momburg F, Pilch H, Huber C, Maeurer MJ, Seliger B.

Int J Oncol. 2001 Dec;19(6):1211-20.

PMID:
11713591
29.

Perineal excision of a large angiomyxoma in a young woman following magnetic resonance and angiographic imaging.

Steiner E, Schadmand-Fischer S, Schunk K, Bezzi I, Weikel W, Pilch H, Knapstein PG.

Gynecol Oncol. 2001 Sep;82(3):568-70.

PMID:
11520157
30.

Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts.

Pilch H, Schlenger K, Steiner E, Brockerhoff P, Knapstein P, Vaupel P.

Int J Gynecol Cancer. 2001 Mar-Apr;11(2):137-42.

PMID:
11328412
31.

The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.

Pilch H, Günzel S, Schäffer U, Tanner B, Brockerhoff P, Maeurer M, Höckel M, Hommel G, Knapstein PG.

Int J Gynecol Cancer. 2001 Jan-Feb;11(1):39-48.

PMID:
11285032
32.

Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.

Pilch H, Günzel S, Schäffer U, Tanner B, Brockerhoff P, Maeurer M, Höckel M, Hommel G, Knapstein PG.

Zentralbl Gynakol. 2001 Feb;123(2):91-101.

PMID:
11265139
33.

Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis.

Hengstler JG, Pilch H, Schmidt M, Dahlenburg H, Sagemüller J, Schiffer I, Oesch F, Knapstein PG, Kaina B, Tanner B.

Int J Cancer. 2001 Mar 20;95(2):121-7.

34.

(A)symptomatic necrotizing arteritis of the female genital tract.

Pilch H, Schäffer U, Günzel S, Schmidt M, Tanner B, Brockerhoff P, Knapstein PG.

Eur J Obstet Gynecol Reprod Biol. 2000 Aug;91(2):191-6.

PMID:
10869794
35.

Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer.

Höhn H, Pilch H, Günzel S, Neukirch C, Freitag K, Necker A, Maeurer MJ.

J Virol. 2000 Jul;74(14):6632-6.

36.

[Angiogenesis in cervical cancer].

Pilch H, Schäffer U, Schlenger K, Hawighorst H, Tanner B, Bahlmann F, Höckel M, Kanpstein PG.

Gynecol Obstet Fertil. 2000 Jan;28(1):29-37. French.

PMID:
10774115
37.

Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.

Pilch H, Günzel S, Schäffer U, Tanner B, Heine M.

Cancer. 2000 Mar 15;88(6):1370-7.

PMID:
10717619
38.

CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7.

Höhn H, Pilch H, Günzel S, Neukirch C, Hilmes C, Kaufmann A, Seliger B, Maeurer MJ.

J Immunol. 1999 Nov 15;163(10):5715-22.

39.

Influence of several solutions used in bypass surgery on the permeability of the endothelium of carotid arteries in New Zealand rabbits.

Schaeffer U, Strohschneider T, Pilch H, Hengstler JG, Tanner B, Stadtmüller A, Hannekum A.

Thorac Cardiovasc Surg. 1999 Aug;47(4):240-3.

PMID:
10522794
40.

Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.

Pilch H, Schäffer U, Schlenger K, Lautz A, Tanner B, Höckel M, Knapstein PG.

Gynecol Oncol. 1999 Jun;73(3):415-21.

PMID:
10366470
42.
43.

Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma.

Hengstler JG, Kett A, Arand M, Oesch-Bartlomowicz B, Oesch F, Pilch H, Tanner B.

Cancer Lett. 1998 Aug 14;130(1-2):43-8.

PMID:
9751255
44.

[Uterine rupture during induced abortion with prostaglandins in the second trimester].

Zieger W, Leveringhaus A, Pilch H, Wischnik A, Melchert F.

Geburtshilfe Frauenheilkd. 1995 Oct;55(10):592-8. Review. German.

PMID:
8543135
45.

Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications.

Weiss J, Heine M, Körner B, Pilch H, Jung EG.

Br J Dermatol. 1995 Jul;133(1):23-31.

PMID:
7669636
46.

Establishment and characterization of a multidrug-resistant human bladder carcinoma cell line RT112/D21.

Seemann O, Muscheck M, Siegsmund M, Pilch H, Nebe CT, Rassweiler J, Alken P.

Urol Res. 1995;22(6):353-60.

PMID:
7740654
47.

Mutation and expression of TP53 in malignant melanomas.

Weiss J, Heine M, Arden KC, Körner B, Pilch H, Herbst RA, Jung EG.

Recent Results Cancer Res. 1995;139:137-54. Review.

PMID:
7597286
48.
49.

[DNA cytophotometry of oxyphilic thyroid tumors].

Pilch H, Back W, Winter J.

Zentralbl Pathol. 1994 Feb;139(6):433-6. German.

PMID:
8161492
50.

Chronic treatment with piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged mice.

Pilch H, Müller WE.

Pharmacopsychiatry. 1988 Nov;21(6):324-5. No abstract available.

PMID:
3244761

Supplemental Content

Support Center